Enter your login e-mail to the account
Search
Search parameters
Search results
- Use of biological treatment in oncology
MUDr. Michal Mego, MUDr. Lucia Masárová
(6/2011, Review articles ) - NOVINKY VO FARMAKOTERAPII: KATEGORIZÁCIA OD 1. JANUÁRA 2009
Ing. Mgr. Dagmar Hroncová
(11/2008, Informations )
- Acute mountain sickness
prof. MUDr. František Novomeský, PhD., prof. MUDr. Egon Kurča, PhD., MUDr. Štefan Sivák, PhD., doc. MUDr. Vladimír Nosáľ, PhD., FESO
(4/2015, Main topic )
- Biologic and targeted therapy for urogenital maliginities
MUDr. Mária Rečková
(1/2011, Review articles ) - Novinky z ASCO 2006
MUDr. Tomáš Šálek, MUDr. Radovan Barilla,
(3/2006, Events ) - mTOR inhibitors in the treatment of advanced renal cell carcinoma
MUDr. Radovan Barilla, PhD., MUDr. Zuzana Syčová-Milá
(1/2009, Review articles ) - The present approach to treatment of renall cell carcinoma
MUDr. Zuzana Syčová-Milá
(5/2010, Review articles ) - Sorafenib and hepatocellular carcinoma
MUDr. Iveta Andrezálová Vochyanová
(1/2014, Drugs & drug classes ) - New mechanism of action in the treatment of renal cell carcinoma: m-TOR – a novel target
MUDr. Hana Študentová, prof. MUDr. Bohuslav Melichar, Ph.D.
(5/2010, Review articles ) - HIF inhibitors and glutaminase inhibitors in the treatment of advanced renal cell carcinoma
MUDr. Zuzana Tomčová
(3/2024, Main topic ) - Pheochromocytoma and paraganglioma
MUDr. Mária Rečková
(2/2013, Main topic ) - Temsirolimus – mTOR as a new target for the treatmet of advanced cell carcinoma (RCC) and relapsed and/or refractory mantle cell lymphoma (MCL)
doc. PharmDr. Juraj Sýkora, CSc.
(5/2009, Drugs & drug classes ) - Nivolumab in the renal cell carcinoma treatment
MUDr. Bc. Patrik Palacka, PhD., MPH, MBA, LL.M., Vladimíra Baranová
(1/2018, Main topic ) - Systemic treatment of metastatic renal cell carcinoma after failure of the first line of treatment
MUDr. Dagmar Sudeková
(1/2018, Main topic )